[go: up one dir, main page]

SG50414A1 - Therapeutic compounds - Google Patents

Therapeutic compounds

Info

Publication number
SG50414A1
SG50414A1 SG1996000871A SG1996000871A SG50414A1 SG 50414 A1 SG50414 A1 SG 50414A1 SG 1996000871 A SG1996000871 A SG 1996000871A SG 1996000871 A SG1996000871 A SG 1996000871A SG 50414 A1 SG50414 A1 SG 50414A1
Authority
SG
Singapore
Prior art keywords
pct
alkyl
image
sec
optionally substituted
Prior art date
Application number
SG1996000871A
Other languages
English (en)
Inventor
Peter Edward Dr Cross
Alan Dr Stobie
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of SG50414A1 publication Critical patent/SG50414A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/44Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/56Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG1996000871A 1991-09-14 1992-09-03 Therapeutic compounds SG50414A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919119705A GB9119705D0 (en) 1991-09-14 1991-09-14 Therapeutic compounds

Publications (1)

Publication Number Publication Date
SG50414A1 true SG50414A1 (en) 1998-07-20

Family

ID=10701448

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996000871A SG50414A1 (en) 1991-09-14 1992-09-03 Therapeutic compounds

Country Status (31)

Country Link
US (1) US5543419A (uk)
EP (1) EP0603229B1 (uk)
JP (2) JP2672030B2 (uk)
KR (1) KR0135784B1 (uk)
CN (1) CN1037269C (uk)
AT (1) ATE167187T1 (uk)
AU (1) AU659487B2 (uk)
BR (1) BR9206499A (uk)
CA (1) CA2116356C (uk)
CZ (1) CZ281752B6 (uk)
DE (1) DE69225897T2 (uk)
DK (1) DK0603229T3 (uk)
EG (1) EG20072A (uk)
ES (1) ES2116343T3 (uk)
FI (1) FI114707B (uk)
GB (1) GB9119705D0 (uk)
GR (1) GR3027667T3 (uk)
HU (1) HU220594B1 (uk)
IL (1) IL103078A (uk)
MX (1) MX9205221A (uk)
MY (1) MY108602A (uk)
NO (1) NO305397B1 (uk)
NZ (1) NZ244324A (uk)
PL (1) PL170627B1 (uk)
PT (1) PT100863B (uk)
RU (1) RU2117669C1 (uk)
SG (1) SG50414A1 (uk)
TW (1) TW251285B (uk)
UA (1) UA42686C2 (uk)
WO (1) WO1993006098A1 (uk)
ZA (1) ZA926939B (uk)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59605542D1 (de) * 1996-01-19 2000-08-10 Lonza Ag Verfahren zur Herstellung von optisch aktivem 3-Chinuclidinol
CZ54498A3 (cs) * 1997-03-07 1998-11-11 Lonza Ag Katalyzátorová směs na bázi amorfního částečně dehydratovaného hydroxidu zirkoničitého a způsob její výroby a použití
US6711436B1 (en) 1997-08-08 2004-03-23 Duke University Compositions, apparatus and methods for facilitating surgical procedures
ATE318595T1 (de) * 1997-08-08 2006-03-15 Univ Duke Zusammensetzungen zur vereinfachung von chirurgischen verfahren
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
ATE305468T1 (de) * 2000-12-22 2005-10-15 Almirall Prodesfarma Ag Chinuclidincarbamat derivate und deren verwendung als m3 antagonisten
SI1353919T1 (sl) 2000-12-28 2006-12-31 Almirall Prodesfarma Ag Novi derivati kinuklidina in medicinske zmesi, kijih vsebujejo.
GB0424284D0 (en) * 2004-11-02 2004-12-01 Novartis Ag Organic compounds
DE102004057995A1 (de) 2004-12-01 2006-06-08 Wacker Chemie Ag Verfahren zur Herstellung von α,α-Dialkyl-α-Hydroxymethyl-Carbonsäurederivaten
ES2298049B1 (es) * 2006-07-21 2009-10-20 Laboratorios Almirall S.A. Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
EP2114972A2 (en) * 2006-12-13 2009-11-11 Gilead Sciences, Inc. Monophosphates as mutual prodrugs of muscarinic receptor antagonists and beta-agonists for the treatment of copd and chronic bronchitis
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843074A (en) * 1988-05-17 1989-06-27 Marion Laboratories, Inc. 1-azabicyclo[2.2.2]octan-3-yl 2-aryl-3-azacyclo-2-hydroxypropionates and their quaternary salts
GB8923590D0 (en) * 1989-10-19 1989-12-06 Pfizer Ltd Antimuscarinic bronchodilators

Also Published As

Publication number Publication date
EP0603229B1 (en) 1998-06-10
IL103078A (en) 1996-07-23
AU2482392A (en) 1993-04-27
ZA926939B (en) 1994-03-11
PL170627B1 (en) 1997-01-31
CZ395392A3 (en) 1994-07-13
DE69225897D1 (de) 1998-07-16
FI114707B (fi) 2004-12-15
UA42686C2 (uk) 2001-11-15
ES2116343T3 (es) 1998-07-16
GR3027667T3 (en) 1998-11-30
EG20072A (en) 1999-06-30
NZ244324A (en) 1993-12-23
JPH06510991A (ja) 1994-12-08
CN1070911A (zh) 1993-04-14
NO940905D0 (no) 1994-03-14
NO940905L (no) 1994-03-14
MX9205221A (es) 1993-03-01
JPH09315970A (ja) 1997-12-09
CN1037269C (zh) 1998-02-04
CZ281752B6 (cs) 1997-01-15
PT100863B (pt) 1999-07-30
RU2117669C1 (ru) 1998-08-20
FI941170A0 (fi) 1994-03-11
MY108602A (en) 1996-10-31
NO305397B1 (no) 1999-05-25
HU9400729D0 (en) 1994-06-28
FI941170L (fi) 1994-03-11
AU659487B2 (en) 1995-05-18
DK0603229T3 (da) 1998-10-12
TW251285B (uk) 1995-07-11
GB9119705D0 (en) 1991-10-30
IL103078A0 (en) 1993-02-21
JP2672030B2 (ja) 1997-11-05
PT100863A (pt) 1993-10-29
WO1993006098A1 (en) 1993-04-01
ATE167187T1 (de) 1998-06-15
CA2116356C (en) 1998-03-31
KR0135784B1 (ko) 1998-04-23
JP2955533B2 (ja) 1999-10-04
EP0603229A1 (en) 1994-06-29
HUT66772A (en) 1994-12-28
US5543419A (en) 1996-08-06
BR9206499A (pt) 1995-11-21
HU220594B1 (hu) 2002-03-28
CA2116356A1 (en) 1993-04-01
DE69225897T2 (de) 1998-10-15

Similar Documents

Publication Publication Date Title
EG20072A (en) Therapeutic compounds
GB9524157D0 (en) Therapeutic agents
GR3034769T3 (en) Triazole antifungal agents.
ZA929914B (en) Therapeutic agents.
DE59304311D1 (de) N-substituierte 3-azabicyclo[3.2.0]heptan-derivate als neuroleptika
PL312582A1 (en) Use of cephem derivatives as antimetastatic means
HU9501317D0 (en) Aza-spiro-alkanes derivatives as therapeutic agents